Covington & Burling LLP

A range of pharmaceuticals, biotechnology companies and medical device manufacturers turn to Covington & Burling LLP for assistance with work including strategic transactions, M&A, fundraising, post-Brexit divergence and issues related to digital health. Grant Castle heads up the team. His far-reaching practice incorporates GXP-related advice to pharma companies, including in relation to pharmacovigilance and manufacturing issues. Solicitor advocate Brian Kelly represents a range of pharmaceutical clients before English courts and EU Courts. Sarah Cowlishaw is noted in the market for her expertise pertaining to digital health. Daniel Pavin has developed a market reputation for handling collaborations and commercial agreements in the life sciences sector. Winsome Cheung is well-placed to guide pharmaceutical companies and innovative biotechnology companies through the intricacies of strategic partnering arrangements, while Raj Gathani is a popular contact for clients looking to launch new medicines, devices and digital health products into the UK market.